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Abstract 
The effectiveness of a multifocal training to improve the treatment of community-
acquired MRSA skin and soft tissue infections 
 
Aaron Santmyire 
Practitioners and researchers have documented an increase in community-acquired 
methicillin resistant staphylococcus aureus (CA-MRSA) skin and soft tissue infections 
(SSTIs). This increase is causing stress and concern for the individuals infected and the 
families of those infected. The impact of a practitioner based multifocal training has not 
been clearly established. The purpose of this capstone project was to determine the effect 
of a multifocal training on CA-MRSA SSTIs that educated primary care practitioners 
about treatment guidelines, Marion County, WV susceptibility data, I&D technique, and 
a patient education tool versus common treatment practices to increase practitioner’s 
knowledge and utilization of evidence based guidelines in the treatment of CA-MRSA 
SSTIs.  Multifocal trainings educated practitioners concerning CA -MRSA SSTIs in 
Marion County, West Virginia.  
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Introduction 
Treatment of patients with community-acquired methicillin resistant 
staphylococcus aureus (CA-MRSA) skin and soft tissue infections (SSTIs) is a major 
challenge and concern in the global health care community. These infections are rapidly 
becoming more prevalent (McCaig et al., 2006) and prevention of further antibiotic 
resistance is of paramount importance (World Health Organization [WHO], 2010). 
Primary health care providers need to know the most effective method of treatment and 
control of CA-MRSA SSTIs in the pediatric population to achieve resolution of infection, 
prevent adverse health outcomes, and limit spread of the infection.  
It is imperative that primary care practitioners know and implement current 
practice guidelines for the treatment of CA-MRSA SSTIs. Despite current 
recommendations for incision and drainage (I&D) to be the primary treatment for 
uncomplicated CA-MRSA SSTIs (Gorwitz, 2008; Liu et al., 2010), substantial practice 
variation in use of I&D and antibiotic prescription persist (Baumann, 2011; Hersh et al., 
2009). Increasing consistency and use of evidence-based care is important to both prevent 
inadequate treatment and improve patient outcomes. Appropriate antibiotic prescribing 
practices are particularly important to help reduce the spread of antibiotic resistance 
(Gorwitz, 2008). Evidence-based practice can potentially both improve patient outcomes 
and reduce the risk of adverse outcomes. The purpose of this paper is to describe the 
implementation and evaluation of a practice change concerning the treatment of CA-
MRSA SSTIs. Implications and recommendations for primary care practice are 
presented. 
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Background and Significance of the Proposed Intervention 
Statement of the Problem 
The prevalence of CA-MRSA SSTIs has been well documented, yet evidence 
suggests practitioners are not following clinical practice guidelines in treatment of these 
infections. Treatment changes are paramount in the fight against CA-MRSA and 
practitioners must follow the clinical practice guidelines and begin to utilize I&D more 
frequently and antibiotics only when warranted. 
Epidemiology of the Problem 
Although antibiotic resistant bacteria are not a new phenomenon, the World 
Health Organization ([WHO]; 2010) has identified the development of antibiotic 
resistance as one of the most significant public health threats of the 21st century. 
Methicillin-resistant staphylococcus aureus (MRSA) is one of these antibiotic resistant 
bacteria, prevalent in the community, contagious, difficult to treat and eradicate, and at 
times, lethal (Newland & Kearns, 2008).  In the 1960s, the first occurrence of MRSA was 
observed in the hospital setting (Barrett, McGhee, & Finland, 1968); hence the label 
hospital-acquired methicillin-resistant staphylococcus aureus (HA-MRSA). Risk factors 
associated with HA-MRSA include prolonged hospitalization, surgical intervention, 
dialysis, close contact with other patients with MRSA, implanted medical devices, and 
admission into intensive care or burn units (Newland & Kearns).  
Until the 1980s, MRSA remained a major problem in the hospital but had not yet 
become a major pathogen in the community (Fergie & Purcell, 2001). In the 1980s, the 
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first individual case of MRSA in the community without the risk factors of HA-MRSA 
was observed. This type of MRSA became known as community-acquired methicillin-
resistant staphylococcus aureus (CA-MRSA).   Herold et al. (1998) reported an 
increasing trend in the 1990s in SSTIs caused by CA-MRSA in patients with none of the 
known risk factors previously associated with HA-MRSA.   CA-MRSA has become a 
major pathogen in the community, specifically affecting the pediatric population in SSTIs 
(Centers for Disease Control [CDC], 2010).  CA-MRSA is a common and serious 
problem, usually involving skin, especially among children (Fridkin et al., 2005). 
Most CA-MRSA infections occur in infants, children, and teenagers (CDC, 2010). In this 
population, 80% of the CA-MRSA infections present as SSTIs. Community onset SSTIs 
account for the majority of MRSA infections in children (Gorwitz, 2008). Children who 
are enrolled in childcare centers, athletes, tattoo recipients, and neonates are at increased 
risk for CA-MRSA SSTIs. Additional risk factors include age (< 2 years), minority race 
or ethnicity, and low socioeconomic status (CDC, 2010). 
Treatment 
Worldwide, clinicians and researchers are addressing the health care challenge of 
CA-MRSA SSTIs.  A key concern associated with treatment of CA-MRSA STTIs is that 
staphylococcus aureus will continue to develop resistance to these remaining antibiotics 
and further limit treatment options. A focus of research has been to identify the most 
efficacious way of treating CA-MRSA SSTIs that will also be the least likely to create 
further antibiotic resistance. A parallel concern has been to avoid unnecessary treatment 
with antibiotics when clinical situations warrant. While there are significant variations in 
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regional susceptibility patterns that influence treatment selected, antibiotics to which CA-
MRSA is currently susceptible include vancomycin, clindamycin, trimethoprim-
sulfamethoxazole, doxycycline and minocycline, daptomycin, and linezolid (Liu etal., 
2011). It must be noted that only clindamycin, trimethoprim-sulfamethoxazole, 
doxycycline (for children 9 years or older), and minocycline (for children 9 years or 
older), are used for treating the outpatient pediatric CA-MRSA SSTI. When empiric 
treatment is warranted, practitioners can use local antibiograms, the compilation of 
individual antimicrobial tests, to know the susceptibility data when choosing an empiric 
antibiotic. 
Antibiotic resistance  
In 1928, Professor Alexander Fleming recognized that a mold was inhibiting the 
growth of bacteria (NIH, 2009). He remarked that this mold was able to repel and destroy 
other bacteria. Fleming’s discovery effectively ushered in the era of antibiotics. For over 
70 years, antibiotics have been used to treat innumerable infections and prolong countless 
lives. However, after many decades of use, and over use, of antibiotics, bacteria have 
developed resistance to them (NIH, 2009). After being exposed to antibiotics, the bacteria 
have altered their genetic structure so that they are no longer susceptible to certain types 
of antibiotics.  
Another important part of the etiology of antibiotic resistance is the process of 
selectively eliminating, intentionally or unintentionally, bacteria from the body. Bacteria 
normally colonize the skin of humans. When an individual’s skin is intact, these bacteria 
are not harmful and are believed to be in some ways beneficial. However, when 
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individuals take or receive antibiotics, these medications theoretically kill or inhibit the 
growth of all bacteria that are susceptible to the antibiotic (NIH, 2009). The bacteria that 
are left on the skin are the ones that are resistant to the antibiotic, and are then freely able 
to multiple and become the dominant bacteria.  
 The problem arises the next time the integrity of the skin is broken or the 
individual has another infection, because these bacteria are no longer susceptible or are 
developing resistance to that type of antibiotic. A different type of antibiotic is needed to 
treat the bacterial infection. After continual cycles of taking antibiotics, it becomes 
increasingly difficult to find antibiotics that are effective against the bacteria that remain. 
It is interesting to note that several of the antibiotics used to treat CA-MRSA, such as 
trimethoprim-sulfamethoxazole, are older medications that had fallen out of favor of the 
medical community for treatment of infections. It is these medications that had not been 
extensively used for some time, that are now at times the first line defense against CA-
MRSA SSTIs (Liu et al., 2011). 
Epidemiology 
Although there is evidence that SSTIs are rapidly increasing across the United 
States, the exact incidence and prevalence of non-invasive MRSA and CA-MRSA are not 
known (CDC, 2010). A major barrier to measuring the incidence and prevalence data is 
that MRSA is not a nationally reportable disease. In the literature, incidence and 
prevalence data are often taken from individual studies and standardized for the United 
States. One such study that is accepted by the Centers for Disease Control (CDC) as 
representative of prevalence for the United States, used the National Ambulatory Medical 
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Care Surveys (NAMCS) and National Hospital Ambulatory Medical Care Surveys 
(NHAMCS) to estimate the prevalence of CA-MRSA SSTIs (McCaig et al., 2006). These 
researchers estimated that in 2005, there were 14 million outpatient visits that were 
suspected staphylococcus aureus and SSTIs.  
Because neither CA-MRSA nor MRSA are reportable to the CDC, neither are 
included in the Morbidity and Mortality Weekly Report (MMWR) published by the CDC 
(2008). Therefore, national and local morbidity and mortality statistics are not collected. 
According to the CDC (2011), the most accurate, currently available assessment of 
morbidity and mortality associated with CA-MRSA is a study conducted by Klevens et al 
(2008). From July 2004 through December 2005, these researchers conducted a 
population-based surveillance for invasive MRSA in nine different sites across the United 
States. The researchers standardized the results from their surveillance and derived a 
standardized mortality rate of 6.3 per 100,000 for all cases of MRSA and 0.5 per 100,000 
for CA-MRSA.   
Description of the Population 
 The target population was practitioners and the patients and families who develop 
or are affected by CA-MRSA SSTIs in Marion County, West Virginia.  
Limitations  
 The population of interest was limited to the practitioners, families, and the 
pediatric population who live in Marion County, West Virginia. There were 23,652 
households in Marion County in 2000 (US Census, 2009). The pediatric population 
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consists of 11,285 children. Of these 11,285 children, 3,176 of these children were under 
the age of 5 years.  
Marion County has over 120 physicians, six family nurse practitioners, and 15 
pharmacists who work within the county. These practitioners vary in ethnicity and 
educational background. For the purpose of this capstone project, medical doctors, 
doctors of osteopathic medicine, physician assistants, nurse practitioners, and pharmacists 
were targeted.   
While no specific demographic data for the practitioner population was available, 
there was demographic data available for the general population of Marion County. The 
ethnic make-up of the population of Marion County is 94.5% White, 3.5 % Black, and 
1.1% Latino or Hispanic (US Census, 2009). English is the primary language spoken at 
home by 97.3% of the population, and Spanish is the second most spoken language at 
1.3% (US Census, 2009). The US Census (2009) also recorded the gender stratification as 
51.9 % female and 48.1% male.  
Demographics and Unique Factors Affecting Care 
 Marion County is located in north central West Virginia. The county seat is 
Fairmont, which is located 20 miles from Morgantown, West Virginia. The total 
population of Marion County is 56,706 (U.S Census, 2009).  The median age is 39.9 
years of age. The population is diversified with part of the population living in rural 
conditions and the other part of the population living in small towns and cities. The 
average annual household income is $36,086 (U.S. Census). Of those who live in the 
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county, 18.8% are living below the poverty line. This is higher than the rest of West 
Virginia, where 17.6 % are living in poverty (U.S. Census). In the past and present, coal 
mining and natural gas have been and continue to be the driving force of the economy. 
Two other large growing employers are Fairmont State University and Fairmont General 
Hospital. Quality medical care is available and the largest provider in the county is 
Fairmont General, which is a large community non-profit hospital.  
 Although CA-MRSA SSTIs can affect the whole community, most CA-MRSA 
infections occur in infants, children, and teenagers (CDC, 2010). In this population, 80% 
of the CA-MRSA infections present as SSTIs. Children enrolled in childcare centers, 
athletes, tattoo recipients, and neonates have been identified by epidemiologists as at 
increased risk for CA-MRSA SSTIs (Baker, 2007). The CDC has also identified that 
children less than two years of age, children of ethnic minority groups, and children of 
parents of low socio-economic status are at increased risk (2010). 
 Low socio-economic status is a barrier to health care access and a risk factor for 
CA-MRSA. In their research on CA-MRSA SSTIs in the pediatric population, Doung et 
al. (2010) remarked that parents of low socio-economic status often use the emergency 
room as the source of primary care for their children. They listed lack of insurance and 
the lack of a family doctor as two major reasons for this. In Marion County in 2000, eight 
percent of those less than 18 years of age had no health insurance coverage. Quality 
health care is available in Marion County, but without health insurance or finances to pay 
for it, it is not accessed effectively. With the number of West Virginians living below the 
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poverty level, the children of Marion County are at increased risk for CA-MRSA SSTIs 
because of their socio-economic status. 
The educational level of those living in Marion County also places the population 
at increased risk for communicable diseases such as CA-MRSA.  Of the adult population, 
79.5 % of the population are high school graduates and 16% hold a bachelor’s degree or 
higher (US Census, 2009). Nineteen percent of Marion County adults have a level 1 
literacy proficiency (the lowest level on a scale of 1-5) (West Virginia Department of 
Education, 2010).  Low literacy is linked to adverse health outcomes such as decreased 
health knowledge and less than adequate use of preventive health services (Agency for 
Healthcare and Quality, 2004). The low literacy level and poverty also negatively affect 
health literacy. In Marion County, these specific negative factors create cultural barriers 
for health education interventions and require that adaptations be made to accommodate 
these barriers.  
Theoretical Framework 
Rogers’s theory of Diffusion of Innovations was used to guide this Doctor of 
Nursing Practice capstone project. The capstone project had as its practice question: what 
is the effect of a multifocal training on CA-MRSA SSTIs that educates primary care 
practitioners about treatment guidelines, Marion County, WV susceptibility data, I&D 
technique, and a patient education tool versus common treatment practices to increase 
practitioner’s knowledge and utilization of evidence based guidelines in the treatment of 
CA-MRSA SSTI?   
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Key Elements of Diffusion Framework 
Everett Rogers developed the theory of Diffusion of Innovations to explain and 
describe social change (2003). In early investigations, Rogers studied the diffusion of 
agricultural innovations and specifically why some farmers adopted new technologies 
and advancements, and others did not. Rogers sought to explain the why, how, and speed 
or rate at which new ideas and practices were spread across the agricultural community  
(Rogers, 2003). To advance the theory, Rogers was able to test it cross-culturally and was 
able to confirm that the theory was applicable in other cultural settings and was not 
unique to the United States. Rogers continued drawing conclusions and identified 
regularities concerning diffusion that are found across cultures, innovations, and the 
social groups that adopt innovations. 
 Rogers identified four main elements of the diffusion process as innovation, 
communication channels, time, and social systems (Rogers, 2003).  
1. Innovation- an idea, practice, or object that is perceived as new by an individual.   
2. Communication channels- the means by which individuals or groups relay 
information for the purpose of reaching a mutual understanding.  
3. Time- a system of measurement that quantifies the rate of passing through an 
innovation process and the speed of adoption.  
4. Social system- a set of interrelated units that are involved in joint problem solving 
to accomplish a goal.  
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The innovation for this capstone project had several components. These 
components were the CDC guidelines on treatment of CA-MRSA SSTIs (Appendix D), 
Marion County susceptibility data for 2011 (Appendix E), I&D instructional video, and a 
patient education tool (Appendix C). It was hypothesized that the one or all of the 
components may be new to the practitioners.  Those practitioners who do not use the 
guidelines in treatment of CA-MRSA SSTIs considered the components an innovation.  
The communication channels for this project were diverse and their utilization 
depended upon the stage of the project. This project utilized both oral and written 
communication to transmit the innovation. In the initial development stages, email, 
telephone calls, and interviews were used to solidify feasibility and acceptability of the 
project. In the educational setting, oral and written communication were used and also 
included technological mediums such as the website (Appendix B) and Powerpoint. 
Communication not only occurred in a didactic form, but was also engaging and 
conversational.  Daly et al. found that physicians who were engaged in discussion on the 
guidelines and barriers were more apt to accept the innovation (2011).  
The element of time was also integrated into the capstone project.  Hader et al. 
(2007) noted in their qualitative study on practice change in physicians that acceptance of 
an innovation is a complex process and not a single decision point. Hader emphasized 
that the rate of this complex process varies. Time was used as a measure of whether the 
multifocal training was effective or not. An example of this was the follow-up evaluation, 
which was sent to practitioners who attended the training. The practitioners were asked 
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questions about whether they had treated patients with CA-MRSA SSTIs and/or used the 
guidelines or website during the follow-up period. 
The element of social systems also guided this project. The culture of 
practitioners has different levels of perceived standing or hierarchy. The question of 
whether medical doctors, who are perceived as on the upper level of the hierarchy, would 
be accepting of instruction or introduction of the innovation by a mid-level nurse 
practitioner was important and may have affected outcomes. Therefore, champions from 
the medical community were sought out for their expertise, insight, direction, and 
influence.  
 Rogers expanded upon the elements of the diffusion process by delineating five 
stages that occur in the adoption process of an innovation. These fives stages are 
knowledge, persuasion, decision, implementation, and confirmation (Rogers, 2003).  
1. Knowledge- the point at which an individual becomes aware of an innovation and 
how it functions. The three stages of knowledge are awareness, application 
knowledge, and principle knowledge.  
2. Persuasion- when an individual forms a perception or attitude towards the 
innovation regardless if it is positive or negative.  
3. Decision – takes place when an individual decides to accept or reject an 
innovation. 
4. Implementation- an individual decides to put an innovation into practice.  
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5. Confirmation- an individual seeking affirmation or reinforcement concerning the 
innovation. 
For this capstone project, the point of knowledge for the practitioners was the day 
of the educational intervention. The goal of the project was for practitioners to move 
beyond the knowledge stage and recognize how the guidelines and resources on the 
website would facilitate application knowledge. From this point of application 
knowledge, practitioners had a greater understanding of their role, or principle 
knowledge, in implementing the innovation.  
The second stage of persuasion could have occurred at different times for 
different practitioners. It may have occurred during, immediately after, or in the days that 
followed the multifocal training. Champions with knowledge and influence provided 
insight and direction for the project, and their support helped persuade other practitioners 
to consider the innovation. Hader et al. identified that physicians take into consideration 
the actions of their peers during the persuasion process (2007). The website also 
persuaded practitioners to adopt the practice change because it simplified the process of 
using the guidelines, addressed common barriers, allowed continuous access, and 
promoted long term sustainability.  
The decision to accept or reject the innovation could have occurred during or after 
the educational intervention. Factors that could have affected this decision were 
presentation style, perceived need, patient acceptance, champion’s support, and 
institutional support. Steps were taken to influence the decision to adopt the innovation, 
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and included demonstration of the website link, opportunity for question and answer, and 
comparison with past multi-drug resistant programs that have provided positive 
outcomes.  These actions correspond to what Daly et al. (2011) noted may influence 
practitioner decision making.  
Implementation of the innovation by practitioners could have occurred at any time 
following the multifocal training.  If a practitioner decided to implement the innovation, 
the implementation occurred when the practitioner treated a case of CA-MRSA SSTI and 
chose to follow the CDC guidelines. The ease of use of the guidelines, susceptibility data, 
and patient education tool should have assisted practitioners who chose to implement the 
innovation to continue to do so.  
During the stage of confirmation, practitioners sought affirmation from others 
concerning the innovation. Other practitioners, patients, family members, and/or the 
capstone committee could have given this affirmation. Confirmation was paramount to 
this projects sustainability. If confirmation was consistent and positive, the probability of 
the innovation being successful should have increased.  
 Recognizing that there are variables that affect the rapidity of acceptance of an 
innovation, Rogers continued his theory by identifying five variables that influence 
acceptance (2003).  
1. Relative advantage- the improvement of the innovation in comparison with the 
current model.  
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2. Compatibility- the relationship of the innovation with the existing values, past 
experiences, and needs of those who potentially would adopt the innovation.  
3. Complexity- the perception of the difficulty to comprehend and implement the 
innovation.  
4. Trialability- the length of commitment needed to experiment with the innovation. 
5. Observability- the extent to which the results of the innovation are visible to 
others.  
These five variables were important for the implementation of the innovation and 
influenced the rate of adoption. First, practitioners needed to consider the relative 
advantage or the improvement of the innovation in comparison to their current practice. 
Second, practitioners were affected by their relationship and experiences with CA-MRSA 
SSTIs, evidence based practice, CDC guidelines, perceived severity of CA-MRSA, and 
their confidence or lack thereof in this innovation. Third, practitioners needed to assess 
the perceived complexity of comprehending and implementing the innovation could have 
also affected the rate of adoption. The website aided in decreasing barriers to use of the 
guidelines. Fourth, practitioners needed to consider the variable of trialability of the 
innovation. Trialability should have not inhibited the rate of adoption because of the 
relative simplicity of its implementation, low cost of implementation, and the speed at 
which practitioners were able to see results.  Fifth, practitioners were affected by those 
who observed the innovation: the patient with the infection, the family of the patient, and 
other practitioners.   
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 Rogers also identified different types of adopters of innovations. He categorized 
these adopters into five groups: innovators, early adopters, early majority, later majority, 
and laggards.  
1. Innovators - are first to adopt an innovation and are risk takers. 
2. Early adopters - are discrete and judicious when adopting innovations.  
3. Early Majority - take a significant amount of time to adopt an innovation. 
4. Later Majority - are skeptical about innovations and wait for the majority to  
       adopt it before doing so. 
5. Laggards - are focused on tradition and have an aversion to change. 
This multifocal intervention targeted all categories of adopters, but focused on 
early adopters, early majority, later majority, and laggards. It was hypothesized that 
innovators would have already implemented the innovation. The other categories of 
adopters could have potentially not had knowledge or have implemented the innovation, 
and therefore, were a target of this project.  
Overall, the theory of Diffusion of Innovations was an excellent guide for this 
capstone project. The projects practice question of what is the effect of a multifocal 
training that educates primary care practitioners about treatment guidelines, Marion 
County, WV susceptibility data, I&D technique, and a patient education tool versus 
common treatment practices to increase practitioner’s knowledge and utilization of 
evidence based guidelines in the treatment of CA-MRSA SSTIs, was strengthened by the 
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theory of Diffusion of Innovations as this theory guided, undergirded, and gave structure 
to this project. 
Project Description 
Evidence Based Guidelines 
 The CDC and the IDSA have published guidelines for the treatment of CA-
MRSA SSTIs. The guidelines provide direction for practitioners for identifying these 
infections, distinguishing severity, need for I&D, and need for empiric antibiotic 
treatment. The guidelines also provide guidance for the choice of an antibiotic in the age 
of CA-MRSA. While the guidelines describe proper treatment, there are several barriers 
that hinder their use. Lack of understanding of the guidelines, lack of knowledge of 
regional susceptibility, and hesitance over use of I&D have all been identified as barriers 
for the practitioner. 
Literature Review and Synthesis 
Search Strategy 
 Computerized literature searches of National Guideline Clearinghouse, CINAHL, 
PUBMED, the Cochrane Library, and the Springer, OVID, and Wiley Science full-text 
databases were performed using the keywords CA-MRSA, skin, soft tissue infections, 
antibiotics, incision and drainage, clindamycin, and trimethoprim-sulfamethoxazole 
(TMP-SMX or TMP-SMZ).  A search strategy was developed for each database using 
similar keywords, and the searches were conducted using various combinations of the 
identified keywords. No limits were placed on publication date or type of article. The 
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search was limited to pediatrics, and to the English and French languages. These searches 
produced 294 hits.  
Study Identification 
A three-step process, using the selection criteria detailed below, was used to 
identify articles to retain or exclude. The first step involved screening the titles and 
abstracts. Articles were excluded if they were not research studies, systematic reviews or 
clinical practice guidelines (n= 265).  If any one of the inclusion criteria was not met, the 
article was not considered for use in this systematic review (n=17). If the title and/or 
abstract did not provide sufficient information to make a determination of whether it met 
inclusion criteria, the full-text article was retrieved for review. The second step involved 
reviewing the full text of articles to verify that all inclusion criteria were met. Articles 
were excluded if they were not studies of treatment of CA-MRSA skin and soft tissue 
infections (n=6), or if incision and drainage was not part of the intervention (n=7). Seven 
articles remained, that met inclusion criteria and were retained for the review. The final 
step of the review process involved hand searching reference lists of all relevant articles 
retained to identify additional relevant articles, which were subsequently retrieved and 
reviewed (n=2). A total of nine articles were included in this review: two clinical practice 
guidelines (CPG) (Stevens et al., 2005; Liu et al., 2011), two randomized control trials 
(RCT) (Doung, Markwell, Peter, & Barenkamp, 2010; Schmitz et al., 2010), three cohort 
studies (Chuck, Frazee, Lambert, McGabe, 2010; Ruhe, Smith, Bradsher, & Mason, 
2007; Teng et al., 2009), one descriptive comparative study (Hyun, Mason, Forbes, & 
Kaplan, 2009), and one expert opinion paper (Newland & Kearns, 2008). The paper by 
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Newland and Kearns was retrieved and first classified as a systematic review; following a 
closer reading of the review, the paper was re-assigned as an expert opinion paper. The 
article was retained for this review because it provided an excellent discussion of the 
prevention and treatment options for pediatric CA-MRSA SSTIs.  
Selection criteria 
Population. The focus of this review is the pediatric population, defined here as 
children ranging in age from 1 year to 18 years. The review excluded studies involving 
neonates. When few randomized controlled trials were identified that studied a pediatric 
population, this criteria was expanded to include adult populations and findings were 
interpreted with respect to transferability to the pediatric population.  
Intervention. The intervention had to address treatment of CA-MRSA SSTIs with 
incision and drainage, either with or without antibiotics active against CA-MRSA. 
Principle outcomes.  The practice outcome of interest was resolution of infection. 
Documents were included that measured this outcome in various ways. 
 Study design. Articles were included if they were a research study, a systematic 
review or a clinical practice guideline. Research studies were included if they were 
randomized controlled trials , controlled trials without randomization, cohort studies, 
observational or comparative studies. Qualitative research and case reports were 
excluded.   
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Methods for quality assessment 
Each of the documents that met the inclusion criteria was assigned a Level of 
Evidence according to Larrabee’s (2009) system of hierarchy.  Studies, reviews and 
practice guidelines are ranked on a scale of 1 – 5 according to strength of design, with a 
rank of 1 (strongest design) assigned to systematic reviews and a rank of 5 (weakest 
design) assigned to case reports, expert opinion papers, etc. The reviewer includes 
consideration of level of evidence with the additional appraisal findings to make a 
determination on the overall quality of each research study, review, and guideline. Table 
1 presents the level of evidence and quality assessment of each article included in this 
systematic review.  
A single reviewer critically appraised the quality of each article included in the 
review. The Appraisal of Guidelines Research & Evaluation (AGREE) network 
guidelines (AGREE, 2006) were used to assess the quality of the CPG (Stevens et al., 
2005; Liu et al., 2011). The standardized AGREE form for review of CPGs focuses on 
the totality of the recommendations, rather than each individual recommendation. The 
CPG is rated on six domains which are scope and purpose, stakeholder involvement, 
rigor of development, clarity and presentation, applicability, and editorial independence 
(AGREE, 2006). The RCTs (Duong et al., 2010; Schmitz et al., 2010), and cohort studies 
(Chuck et al., 2010; Ruhe et al., 2007; Teng et al., 2009) were assessed according to 
Scottish Intercollegiate Guidelines Network (SIGN) guidelines (SIGN, 2007). Quality 
assessment of the descriptive comparative study (Hyun et al., 2009) was accomplished 
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with a standardized assessment form according to methodology developed by Larrabee 
(2009). 
Data Abstraction 
 Data were abstracted from the six studies included in the review as part of the 
quality assessment process. A single reviewer entered data detailing characteristics of the 
included studies . More detailed and specific data about the interventions and outcomes 
were abstracted and entered in a separate table to facilitate summary and synthesis of 
findings across studies. The analysis of similarities and differences across samples, 
interventions, definitions and measures, and outcomes, form the basis of 
recommendations for practice.   
Study Characteristics 
Characteristics of the studies included in this review are displayed in Table 1. The 
settings for all six studies varied in location and specific size and type of center.  Most of 
the studies took place in civilian medical centers (Chuck et al., 2010; Duong et al., 2010; 
Ruhe et al., 2007; Teng et al., 2009; Hyun et al., 2009). One study was conducted in 
military medical centers that sees both civilians and military personnel (Schmitz et al., 
2010). Five studies were conducted in the U.S., one in multiple regions (Schmitz et al., 
2010), two in the south (Hyun et al., 2009; Ruhe et al., 2007), one in the mid-central 
region (Duong et al., 2010) and one on the west coast (Chuck et al., 2010). Only one 
study was conducted outside the U.S., in Taipei, Taiwan (Teng et al., 2009).  
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Data collection methods varied across studies. Retrospective record review was 
used in four cases (Chuck et al., 2010; Hyun et al., 2009; Ruhe et al., 2007; Teng et al., 
2009). The two RCTs (Duong et al., 2010; Schmitz et al., 2010) collected data 
prospectively. Sample sizes ranged from 50 patients (Chuck et al., 2010) to 492 patients 
(Ruhe et al., 2007).  Three study samples comprised adult participants (Chuck et al., 
2010; Ruhe et al., 2007; Schmitz et al., 2010) with a median age of 27 years , 40 years 
(Chuck et al.), 47 years (Ruhe et al.), and 40 years (Schmitz et al.), The other three study 
samples were of pediatric participants with median age of the studies being 4 years 
(Duong et al.), 4.3 years (Hyun et al.), and 6.3 years (Teng et al.).  
 All studies differed in terms of clinical characteristics of the participants, as well 
as type and severity of the skin and soft tissue infection.  In the studies with adult 
subjects, two included participants with comorbid conditions such as diabetes (Ruhe et 
al., 2007; Chuck et al., 2010), while the other study excluded comorbid conditions such 
as diabetes (Schmitz et al., 2010). Two studies, one in the pediatric population (Teng et 
al., 2009) and one in the adult population (Ruhe et al., 2007) characterized SSTIs as 
defined complicated, SSTIs by providing examples of complicated SSTIs such as a non-
healing ulcer or diabetic foot infection, postsurgical wound infection, or processes 
involving deep tissue structures (e.g.,  which include bone, fascia, or tendon sheaths). 
Chuck et al. also chose to define complicated SSTIs, but differently than the others. Their 
definition varied from the definition offered by Teng et al. and Ruhe et al. Doung et al. 
complicated as abscesses with surrounding cellulitis or infection in 
inmmunocompromised hosts or infected wounds. With this variability of definition of 
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uncomplicated versus complicated SSTIs in studies, there is no clear definition to 
distinguish uncomplicated from complicated SSTIs.  More important to this systematic 
review, the use of antibiotics or non-use of antibiotics was based on whether a SSTI is 
complicated or uncomplicated.  
Interventions and Outcomes 
Another area of heterogeneity was in the interventions which were the treatments 
of CA-MRSA SSTIs. All studies used I&D, but the antibiotics, duration, and dosage 
varied. Duration of treatment with antibiotics ranged from seven (Schmitz et al., 2010) to 
ten days (Duong et al., 2010). Dosage of antibiotics prescribed were trimethoprim-
sulfamethoxazole 160mg/800mg two pills twice daily (Schmitz et al., 2010) and 
trimethoprim-sulfamethoxazole 10-12mg trimethoprim /kg/day divided in two doses with 
maximum does of 160mg trimethoprim/dose (Duong et al., 2010).  The other four studies 
were retrospective in design and did not discuss length of treatment or dosage.  Chuck et 
al presented multiple possibilities of antibiotics according to the algorithm, Hyun et al. 
examined trimethoprim-sulfamethoxazole compared to clindamycin, Ruhe et al. and 
Teng et al. examined active or inactivity of susceptibility of prescribed antibiotics. The 
dosage and length of treatment with antibiotics could affect resolution and further spread 
of the CA-MRSA SSTIs (Newland & Kearns, 2008).   
 The outcomes of interest in these six studies were some version of treatment 
success or resolution of infection. As with the interventions, however, specific definitions 
and measurement strategies differed across all studies. Three studies identified treatment 
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failure as the principal outcome (Ruhe et al., 2007; Schmitz et al., 2010; Teng et al., 
2009) Ruhe et al. and Teng et al. define this as worsening signs of infection at least two 
days after zero time with one or more of the following: additional I&D, subsequent 
hospital admission, new infection during antimicrobial therapy or persistence of MRSA 
from wound site, and/or need of surgical intervention. The definition of treatment failure 
by Schmitz et al. was similar to that of Ruhe et al. and Teng et al., but further delineated 
worsening of infection by defining it as increased diameter of abscess or cellulitis, fever, 
systemic response, and/or new lesion development within seven days of time zero.  One 
study measured clinical resolution or failure as the primary outcome of interest (Doung et 
al.), and defined resolution as absence of erythema, warmth, induration, fluctuance, 
tenderness, and drainage at 10 day follow-up. Treatment and failure was defined as 
worsening of signs and symptoms before 10 day follow-up requiring drainage, change in 
medication, hospital admission for intravenous antibiotics, and/or new lesion 
development within 5 cm of original abscess.  
Findings 
Evidence from the studies appraised is homogenous for the use of I&D in the 
treatment of uncomplicated CA-MRSA SSTIs, but the evidence for the use of empiric 
oral antibiotics with I&D is heterogeneous. Use of I&D alone for treatment of 
uncomplicated CA-MRSA SSTI is recommended in the CPG (Stevens et al., 2005; Liu et 
al.,2011), the expert opinion paper (Newland & Kearns, 2008), two RCTs (Duong et al., 
2010; Schmitz et al., 2010), one cohort study (Teng et al., 2009), and the descriptive 
comparative study (Hyun et al., 2009). Definitions of uncomplicated differed across 
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studies, however. Use of I&D and antibiotics active against CA-MRSA for what were 
characterized as complicated SSTI in adult patients was associated with fewer treatment 
failures than occurred in patients who did not receive antibiotics active against CA-
MRSA (Chuck et al., 2010).   
One cohort study suggested that antibiotics active against CA-MRSA provided 
clinical improvement and noted a statistically significant difference at 48 hours between 
those who were started on antibiotics and those who where not (Ruhe et al., 2007). 
Schmitz et al. (2010) and Doung et al. (2010) suggested that trimethoprim-
sulfamethoxazole may decrease the spread of CA-MRSA SSTI after the appearance of 
the first lesion.  
Discussion 
 Overall, this review supports findings of use of incision and drainage alone for 
treatment of uncomplicated CA-MRSA SSTI in pediatric patients, when uncomplicated is 
defined as being an acute single infectious erythematic lesion of the skin or soft tissue 
that is anatomically located in an area in which I&D can adequately be performed and 
does not involve adjacent deep tissue structures in an immuno-competent patient who has 
no signs of systemic infection.  Complicated CA-MRSA SSTI should, at a minimum, be 
defined as an infection of the skin or soft tissue structures that does not meet the minimal 
requirements of an uncomplicated infection. Although this topic is of considerable 
interest among researchers, and numerous studies have been conducted, relatively few 
have used randomized controlled trials. Use of the RCT design is recommended for 
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intervention research (Polit & Beck, 2011). Also noted is the scarcity of research with 
pediatric participants. Although research with pediatric participants, a vulnerable 
population, can be challenging (Polit & Beck), high quality evidence to guide treatment 
of pediatric patients is essential, particularly evidence about use of medications. Most of 
the existing research findings indicate that antibiotics in addition to incision and drainage 
are not necessary to achieve resolution of infection. However, substantial differences 
exist across studies in the definition of uncomplicated and complicated infections. The 
results of this review highlight several gaps in the research evidence about an effective 
treatment for uncomplicated CA-MRSA SSTI in pediatric patients.  
There are several gaps that were identified in the evidence related to SSTIs and 
CA-MRSA. The first identified gap is the lack of clear and consistent definitions across 
studies for uncomplicated and complicated SSTIs, resolution of infection, and treatment 
failure. This limits ability to synthesize findings across studies, and to draw strong 
conclusions about the evidence. The second identified gap is the varying definitions of 
CA-MRSA. In two studies (Ruhe et al., 2007; Teng et al., 2009), CA-MRSA is defined as 
a specimen positive for MRSA, obtained on an outpatient visit or within 48 hours of 
admission, and also lacking all of the risk factors for HA-MRSA. Details related to 
diferentation of CA-MRSA from HA-MRSA were not provided in two studies (Hyun et 
al., 2009; Schmitz et al., 2010). Duong et al. defined CA-MRSA as MRSA obtained from 
a patient from the community susceptible to other antibiotics including vancomycin, 
trimethoprim-sulfamethoxazole, clindamycin, and tetracyclines. Newland and Kearns 
(2008) recommend molecular determination, clinical presentation, and presence of risk 
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factors to identify CA-MRSA. Inconsistent identification of the infection being treated 
means that some may be considered to have an effect on CA-MRSA that does not exist, 
because the SSTI was not actually caused by CA-MRSA. The third identified gap in the 
evidence is the lack of research, beyond the RCTs, with findings suggesting a benefit 
from use of trimethoprim-sulfamethoxazole for prevention of secondary lesions. These 
studies suggest an avenue for research that has not yet been addressed. Long-term follow-
up for intervention studies for CA-MRSA SSTIs will help researchers and practitioners 
understand whether the sentinel infection recurs, if repeated infections are more likely 
among patients who have a history of infection, or if a particular treatment is associated 
with more or less likelihood of recurrent infection.  
 Weaknesses in the methodology of the reviewed studies were identified. 
Compliance with treatment was defined in one RCT (Doung et al. 2010) as taking 50 % 
or more of prescribed medication. The researchers verified the amount of medication 
taken by quantifying study medication on the return visit or parental report over the 
phone (Doung et al., 2010).  Although there is no specific percentage that signifies 
adequate adherence to medications, 80% is commonly seen in the literature as acceptable 
(Andrade, S.E., Kahler, K.H., Frech, F., Chan, A., 2006). The level of 50% is far below 
this average and could be a confounder in this study.  
Duration of follow up after treatment was finished was limited to 30 days in two 
studies (Hyun et al., 2009; Schmitz et al., 2010), 90 days in one study (Doung et al., 
2010), and was unspecified in two studies (Ruhe et al.,2007; Teng et al., 2009). One RCT 
(Schmitz et al., 2010) noted the poor follow-up (69%) at 30 days following infection.  
!!
!
!
!
%+!
Both RCTs (Doung et al., 2010; Schmitz et al., 2010) were convenience samples among 
emergency department patients and may affect generalizabilty. Convenience sampling 
imparts the risk of selection bias.  
One RCT noted there was no standardized I&D procedure and practitioners did 
not follow a standardized protocol for measurement and assessment of the SSTIs 
(Schmitz et al., 2010), one RCT had a standardized protocol (Duong et al., 2010), one 
study described the I&D as an operating room procedure using general anesthesia (Hyun 
et al., 2009), and the other three studies did not describe I&D procedures or its 
standardization (Chuck et al., 2010; Ruhe et al., 2007; Teng et al., 2009). This lack of 
information and standardization makes it impossible to replicate the studies.  
Two cohort studies had small group sizes for their cohorts and did not provide 
confidence intervals (CI) (Chuck et al., 2010; Teng et al., 2009). Two studies did not 
provide details of a power analysis which affects the ability to differentiate if I&D, 
antibiotics, or both were responsible for resolution (Chuck et al., 2010; Hyun et al., 
2009).  Another study included multiple infections from the same persons in the study 
and failed to provide a clearly defined explanation of treatment failure (Ruhe et al., 
2007). There were several threats to internal validity in the descriptive comparative study. 
As a significant variance from the other studies the majority of the participants was 
admitted to the hospital and received parenteral clindamycin before discharge (Hyun et 
al., 2009). The administration of clindamycin could have acted as a confounder in this 
study. This study did not include CIs that would allow for assessment of the power of the 
study. 
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Despite these methodological limitations, some key findings of the review merit 
discussion. Evidence from the studies appraised is homogenous for the use of I&D in the 
treatment of uncomplicated CA-MRSA SSTIs. The CPG (Stevens et al., 2005), two 
RCTs (Duong et al., 2010; Schmitz et al., 2010), one cohort study (Teng et al., 2009), the 
comparative/descriptive study (Hyun et al., 2009), and the expert opinion paper (Newland 
et al., 2008) supported the use of I&D alone in treatment of uncomplicated CA-MRSA 
SSTIs.  
The evidence for the use of empiric oral antibiotics with I&D is heterogeneous. 
One cohort study supported the use of an algorithm with antibiotics active against CA-
MRSA in the treatment of uncomplicated SSTIs, but advised the practitioner to strongly 
consider not using antibiotic therapy (Chuck et al., 2010). One cohort study suggested 
that antibiotics active against CA-MRSA provided clinical improvement and noted a 
statistically significant difference at 48 hours between those who were started on 
antibiotics and those who where not (Ruhe et al., 2007). Schmitz et al. (2010) and Doung 
et al. (2010) suggested that trimethoprim-sulfamethoxazole may decrease the spread of 
CA-MRSA SSTIs after the appearance of the first lesion.  
Dissemination Methods 
 Two studies were identified that addressed the education of practitioners 
concerning evidence based treatment of CA-MRSA SSTIs. The first is an Iowa Research 
Network Intervention (IRENE) study that had as its objective to identify best methods 
and procedures for primary care practitioners to treat SSTIs (Daly et al., 2011). The study 
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was a preintervention/postintervention design and had as its main outcome measure the 
use of antibiotics that would cover MRSA on intial visit and at any time.  Educational 
meetings were conducted that discussed CA-MRSA SSTIs treatment including the CDC 
guidelines and office policies on treatment. The researchers concluded that the CDC 
guidelines are applicable and functional in the primary care office setting and that after 
SSTI management discussions practitioners increased use of antibiotics with MRSA 
coverage both initially and overall (Daly et al.,2011). The researchers also concluded that 
including practitioners in discussions concerning guidelines was more effective than just 
providing guidelines in changing physician practice.  
 The second study conducted an electronic chart audit to investigate the prevalence 
of CA-MRSA and those cases that were treated according to the CDC guidelines on 
outpatient management of CA-MRSA SSTIs (Parnes et al.,2011).  A historical cohort 
was compared with an intervention cohort that received education and  a ready made kit 
for education and treatment of CA-MRSA SSTIs. Researchers concluded that the 
intervention group increased use of antibiotics that covered CA-MRSA, but did not 
increase use of I&D or culture (Parnes et al.,2011). The researchers questioned the results 
of the lack of increase in I&D procedure and hypothesized that possibly the I&D 
procedure was being conducted and not coded, and recommended relying more on a 
physician or point of care data collection method rather than chart audits or electronic 
data capture as the “gold standard.” 
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Implications for practice 
Practitioners and researchers have documented an increase in pediatric CA-
MRSA SSTIs. Therefore, an efficacious and judicious treatment plan is needed to treat 
pediatric CA-MRSA SSTIs and slow the further development of antibiotic resistance.  
Based on this review, treatment of uncomplicated pediatric CA-MRSA SSTIs with I&D 
is recommended. This review does not identify conclusively that the use of antibiotics 
decreases initial uncomplicated CA-MRSA SSTI resolution, but does support the 
possibility that use of antibiotics may decrease secondary lesions. This possibility is 
suggested by evidence from a single study, however, and should be considered tentative. 
Evidence suggests that choice and timing of initial antibiotic and I&D for treatment of 
SSTIs affects speed of resolution and subsequent lesion outcome. When choosing to treat 
a pediatric patient for an uncomplicated CA-MRSA SSTIs, the practitioner needs to 
consider patient history, location of the infection, size of lesion, community prevalence of 
CA-MRSA and its susceptibility, history of antibiotic use, family or close contact history 
of CA-MRSA, immunocompetence, and physical signs of the patient. The 
recommendations from this review are dependent on both the definition of uncomplicated 
and complicated SSTIs and the definition of CA-MRSA.  Treatment recommendations 
depend on accurate identification of CA-MRSA and definition of uncomplicated versus 
complicated SSTIs. It is paramount that practitioners and researchers be aware of the 
variations in the definitions of uncomplicated and complicated SSTIs and CA-MRSA that 
have been used in studies. Practitioners and researchers should compare their definition 
with those used in the studies to assure their definition matches those used in the studies.   
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Future research should focus on RCTs in the pediatric population, include a 
standardized, reliable, method for identification of CA-MRSA, and provide clear and 
explicit definitions of uncomplicated versus complicated SSTIs. Consideration of how 
short and long-term resolution and treatment failure should be defined and measured, is 
important to support confidence in treatment effect. In the area of resolution of infection, 
future studies could also focus on the both the short and long-term benefits of using 
antibiotics with the sentinel SSTI. If I&D is adequate to treat the initial SSTI and provide 
short-term resolution, but subsequent lesions occur days and months after, then it may be 
necessary to consider long-term resolution and possibly antibiotic use when initially 
treating the sentinel lesion.  
There are multiple recommendations for practice as a result of this systematic 
review. First, practitioners must assess and reflect on their current practice of identifying, 
classifying, and treating SSTIs. In this reflection, it is important for practitioners to 
consider their I&D technique and their comfort level with I&D. Second, it is 
recommended that practitioners evaluate how long they follow-up patients and their 
family members treated for SSTIs and assess if this follow up is adequate to assess for 
both short and long-term resolution.  In practices with multiple partners, it is 
recommended that a standardized classification and treatment plan be agreed upon and 
followed. It is recommended that practitioners agree upon what classification of SSTIs 
warrants the use of antibiotics. This will enable continuity of care for SSTIs within the 
practice and allow for follow up data on efficacy to be collected. Third, a 
recommendation would be a continuing education initiative targeting both clinicians and 
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families. These initiatives could address the adherence to accepted treatment plans among 
practitioners and present guidelines an interactive session, since these types of session 
have been shown to increase practitioner adherence over purely didactic sessions.  
Educational activities for families could equip them in the prevention and early 
recognition of CA-MRSA SSTIs.   
Project 
Background 
Practitioners and researchers have documented an increase in community-
acquired methicillin resistant staphylococcus aureus (CA-MRSA) skin and soft tissue 
infections (SSTIs). This increase causes stress and concern for the individuals infected 
and the families of those infected. Practitioners are confronted with evolving bacterial 
resistance, lack of understanding of the CDC guidelines, lack of patient educational tools, 
and insufficient skill in performing I&D. Therefore, a multifocal training that educated 
primary care practitioners about the CDC treatment guidelines for SSTIs, Marion County, 
WV susceptibility data, I&D technique, and a patient education tool was introduced to 
practitioners in Marion County, WV.  
Theoretical Framework 
 Everett Rogers’s theory of Diffusion of Innovations was used to guide this 
project. Rogers developed the theory of Diffusion of Innovations to explain and describe 
social change. Initially, Rogers studied the diffusion of agricultural innovations and 
specifically why some farmers adopted new technologies and advancements and others 
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did not. Rogers continued drawing conclusions and identified regularities concerning 
diffusion that are found across cultures, innovations, and the people who adopt the 
innovations.  
For the purpose of this project, the theory’s five stages that occur in the adoption 
of an innovation were used to frame the steps to be taken to implement change in the 
treatment of CA-MRSA SSTIs. Evidence from the systematic review revealed that 
practitioners were not using an evidence-based approach when treating these infections, 
and change in treatment practice was imperative. Therefore, the investigator focused on 
moving practitioners from knowledge to implementation via the steps of knowledge, 
persuasion, decision, implementation, and confirmation.  
A parallel application of the theory of Diffusion of Innovations in this project was 
the targeting of the different adopters of change. For this project, early adopters, early 
majority, late majority, and laggards were targeted for moving from knowledge to 
implementation of evidence based treatment of CA-MRSA SSTIs. Rogers identified 
these groups as those who have some resistance to change.  
Goal 
The purpose of this capstone project was to assess the effectiveness of a 
multifocal training to improve the treatment of CA-MRSA SSTIs in Marion County, WV. 
The theory of Diffusion of Innovations provided structure and guidance for the project. 
Practitioners were provided with a multifocal training and corresponding website 
(innovation). The training and the website were used to encourage (persuasion) them to 
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begin to use evidence based guidelines and provide them with the resources to do so. 
After the completion of the multifocal trainings, practitioners made the decision to follow 
the evidence based guidelines and use the website resource. Implementation of the 
innovation occurred when the practitioners used the guidelines and resources.  
Confirmation occurred by monitoring hits on the website and practitioner feedback.  
Setting for Project 
Marion County is located in north central WV. The county seat is Fairmont, 
which is located 20 miles from Morgantown, WV. The total population of Marion 
County is 56,706 (U.S Census, 2009).  The median age is 39.9 years of age. While there 
were no specific data available on the total number of practitioners in the county, it was 
known that there are more than 120 practitioners with practice privileges at Fairmont 
General Hospital (FGH).  
The site for the capstone project was FGH, which is located in Marion County. 
The hospital’s mission statement is “making a difference in people’s lives.” FGH vision 
statement is “THE respected name in healthcare.” FGH has a statement of values that 
emphasizes their commitment to service, excellence, integrity, respect, and compassion. 
By promoting the use of evidence-based guidelines for the treatment of CA-MRSA 
SSTIs, this project is congruent with the mission, vision, and values of FGH and 
reinforces its commitment to these.  
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Project Objectives 
The specific outcomes that were measured as part of this capstone project were: 
practitioner knowledge and subsequent utilization of the CDC guidelines on treatment of 
CA-MRSA SSTIs, antibiogram, I&D, and patient/family education following a 
multifocal training as evidenced by improvement of scores from pretest to posttest, no 
loss of knowledge at three month follow up, and self-report of utilization of the 
guidelines and website in treatment of CA-MRSA SSTIs. Following are the specific 
objectives of the project: 
1. By completion of the multifocal training, practitioners will improve their 
knowledge of CA-MRSA SSTIs evidenced by improved scores on the pretest to 
posttest.  
Specifically practitioners will be able to: 
a. List the basic treatment pathway outlined in the CDC guidelines 
(Appendix D) for the treatment of CA-MRSA SSTIs. 
b. List antibiotics (Appendix E) that can be used to effectively treat CA-
MRSA SSTI in Marion County, WV. 
c. Identify proper technique for I&D. 
d. List one tool (Appendix C) for educating patients and families about CA-
MRSA. 
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e. Identify the website (Appendix B) that provides the components of the 
guidelines, antibiogram, I&D video, and patient education tool.  
2. Practitioners self-report using the CDC guidelines, antibiogram, I&D, and 
patient/family education tool in treatment of patients with CA-MRSA SSTIs on 
the three month follow up evaluation.   
3. Knowledge gained from the multifocal training will not be decreased at three- 
month follow-up as evidenced by maintenance of first posttest scores. 
4. The website will have fifty hits on the site by the three-month follow-up date.  
Design 
This capstone project was designed to promote a practice change in the treatment 
of CA-MRSA SSTIs by utilizing a multifocal training to educate primary care 
practitioners about the CDC’s evidence-based guidelines and present tools to address the 
barriers that prohibit practitioners from using the guideline.  
Training for the practitioners included: 
1. Administration of an author developed pretest (Appendix G) to assess 
practitioners’ knowledge of the CDC guidelines, antibiogram, I&D and patient 
education tools were administered before the presentation.  
2. Presentation of current antibiotic resistance, CDC guidelines, regional 
antibiogram, techniques for I&D, and a patient educational tool (Appendix C). 
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These presentations occurred in a lunch or dinner setting with the voluntary 
participation.  
3. Use of the website (Appendix B) that provided practitioners with access to the 
guidelines, antibiogram, I&D video, and patient education tool was emphasized.  
4. Dialogued with practitioners to address their concerns and barriers to using the 
CDC guidelines. 
Resources 
 Resources for this project were identified during the preparation stage. Barriers 
and facilitators were considered so that judicious planning would make wise use of 
available financial and personnel resources.  The investigator identified the following 
resources as paramount for this projects success: expert committee and contributors, 
permission for use of materials, participants, and a budget plan.  
 The expert capstone committee and contributors provided the foundation for this 
project.  Dr. Alvita Nathaniel served as the chair and provided the structure and expertise 
in conducting a capstone project. Janet Crigler, Director of Infection Control at FGH, 
provided invaluable support, insight, and community influence, which greatly contributed 
to this project meeting its outcomes. Crigler was initially contacted early on in the 
preparation stage of the project. She provided contact with contributor, Dr. David Meyer. 
Meyer was instrumental in giving insight into interpretation and use of FGH’s 
antibiogram. Meyer suggested contacting Dr. Uday Kumar, infectious disease specialist 
at FGH, for his insight and thoughts. Kumar recommended the use of the Michigan 
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Antibiotic Resistance Reduction Coalition (MARR) pamphlet for an educational tool for 
the project. Dr Michael Levitas has provided instruction and mentorship throughout the 
investigator’s career, and continued to do so throughout this project.  He served on the 
capstone committee and provided expert insight into the treatment of CA-MRSA SSTIs 
specifically for the pediatric population, which is most affected by CA-MRSA SSTIs.  
 Permission for use of materials was a necessary resource for this project and 
obtaining permission required a significant amount of time. The CDC was contacted first 
about posting the guidelines on the website. Permission was given, as the guidelines are 
public access.  Both Janet Crigler and Dr Meyer provided assistance in securing 
permission from FGH to use the hospital’s antibiogram. Dr. Kumar suggested contacting 
MARR to obtain their permission to use their educational handout. Jane L.Finn granted 
permission from MARR. The New England Journal of Medicine was contacted and 
permission was granted by Jennifer Moran to use the I&D video that was produced for 
the journal.  
A budget plan assisted in focusing financial resources in strategic areas. 
Appalachian Spring Dermatology provided the financial resources necessary for the 
webpage, multifocal trainings, office supplies, and evaluations. FGH contributed the 
expertise of Janet Crigler and David Meyer and its antibiogram. The space needed for the 
teachings was provided without charge by each participating clinic. The expertise and 
time of the members of the capstone committee, Alvita Nathaniel, Janet Crigler, and 
Michael Levitas, and contributors, Uday Kumar, David Meyer, and Beth Rosenberger, 
were paramount for consensus of this project, but it was difficult to assign a financial 
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amount for their time and expertise. Overall, the cost of the project was minimal in 
comparison with its impact. Practitioners’ use of evidence-based guidelines, exercise of 
antibiotic stewardship, and the optimization of use and limitation of misuse of antibiotics 
are invaluable.   
Timeline of Project Phases  
 A timeline was first developed in the planning stages of the project. Activities 
were divided up according to whether they fell in one of three sections: preparation, 
implementation, or evaluation. Although, the dates that were originally assigned to the 
timeline changed, the actions remained the same.  
Preparation  
The activities that occurred during this stage included those that needed to be completed 
before the stage of implementation.  
• The investigator obtained permissions from the CDC, New England Journal of 
Medicine, FGH, and MARR for use of their perspective materials for this project.  
• The investigator met with the WVDHHR concerning the project and possibility 
for statewide adoption.  
• A website (http://wvcamrsa.com) was developed by the investigator as an 
ongoing resource for which practitioners could refer. 
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• The investigator scheduled meetings with clinics within Marion County, WV for 
the multifocal trainings.  
 
Implementation 
This stage consisted of the multifocal trainings and gathering of data that would be used 
in the final stage of evaluation.  
• From July 22, 2012 to August 10, 2012, the investigator conducted multifocal 
trainings at six different clinics in Marion County. These multifocal trainings 
consisted of consent for participation, pretest, instructional and interactive 
training, posttest, and explanation and distribution of follow-up evaluation.  
• The website (http://wvcamrsa.com) was launched on July 22, 2012, which was the 
day of the first multifocal training.  
Evaluation 
This stage consisted of evaluating the gathered data from the pretest, posttest, and three- 
month follow-up evaluation.  
• The investigator obtained 22 pretests and 22 posttests from participants at six 
clinics in Marion County, WV. 
• The investigator conducted statistical tests to analyze the data and to ascertain the 
significance and effectiveness of the training.  
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• The investigator examined the retention of knowledge and the movement from 
knowledge to implementation from the three-month follow-up evaluation.  
• The investigator monitored unique hits on the website throughout the study 
period.  
The project was conducted at six clinics in Marion County, WV with 22 participants. The 
data collected from the pretest, posttest, and three- month follow-up were evaluated. The 
results from the project will be submitted to the WVDHHR for the purpose of initiating 
the project on a statewide level.  
Evaluation 
Following the data collection, the investigator evaluated the project objectives. The 
first objective was: By completion of the multifocal training, practitioners will improve 
their knowledge of CA-MRSA SSTIs evidenced by improved scores on the pretest to 
posttest. This objective was met. There were six multifocal trainings conducted that 
consisted of sixteen doctors, three nurse practitioners, and three physician assistants. 
Following the multifocal training, all participants’ knowledge improved from pretest to 
posttest. 
The second objective was: Practitioners self-report using the CDC guidelines, 
antibiogram, I&D, and patient/family education tool in treatment of patients with CA-
MRSA SSTIs on the three- month follow- up evaluation. This objective was met. Six 
practitioners reported using the CDC guidelines, antibiogram, I&D, and patient education 
tool in treatment of CA-MRSA SSTIs. Two participants reported referring other 
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practitioners, who did not participate in this study, to the website and one participant 
reported referring a drug sales representative to “spread the word.” 
The third objective was: Knowledge gained from the multifocal training will not be 
decreased at three- month follow- up as evidenced by maintenance of first posttest scores. 
This objective was met. However, the number of submitted follow-up evaluations was 
low. There were six follow- up evaluations received. However, only two of these six 
were totally completed evaluations. These two evaluations received scores equaling those 
on their posttest, demonstrating retention of knowledge and no loss of knowledge at the 
three -month follow-up evaluation.   
The fourth objective was: The website will have fifty hits on the site by the three-
month follow-up date. This objective was met. On July 26, 2012, the fourth day following 
the website launch, the fiftieth hit on the website was recorded. The website was readily 
accessed throughout the investigation period.  
Project Results 
The purpose of this project was to train practitioners in Marion County, WV on the 
CDC guidelines for treatment of CA-MRSA SSTIs and to provide resources to address 
some of the most common barriers that inhibit practitioners from using the guidelines.  
Research supports the use of these guidelines and has also supported that there are 
common barriers to not using the guidelines.  Evidence-based treatment of SSTIs is 
imperative to decreasing the rapidity of antibiotic resistance and practicing antibiotic 
stewardship.  
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After discussing this project with WVDHHR, it was decided that this project should 
not be focused statewide, but rather should be “piloted” in one county to examine 
whether there was a need. Marion County was chosen as the county to pilot the program. 
There were five areas of data collection that were used to provide framework for 
evaluating the effectiveness of the multifocal training.  
The first area of data collection in the evaluation process was demographics of the 
participants. The participants included sixteen doctors, three nurse practitioners, and three 
physician assistants. The range of years in practice ranged from several months to more 
than twenty-five years of practice. The gender make up of the participants was thirteen 
males and nine females.  
The second area of data collection in the evaluation process was the results of the 
pretest and posttest that assessed the knowledge acquisition and effectiveness of the 
educational program.  The data was examined to see if there was any significance 
between the pretest and posttest and to examine whether or not the multifocal training 
was effective. There were nine questions on the identical pretest and posttest. A paired t-
test was conducted comparing the results. The null hypothesis that there was no 
significant difference or lack of knowledge acquisition in comparing pretest to posttest 
scores was rejected. The one tailed t-test revealed that the posttest scores were greater 
(m=8.32,s=.716) compared to pretest scores (m=4.45, s= 2.132), t(21) = -7.897, p<.05 . 
Thus, the first objective was met.  
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The third area of data collection was the results of the three-month follow-up 
evaluations. The data was examined to assess for knowledge retention at the three-month 
follow-up period. Of the six follow-up evaluations received, only two were totally 
completed. These two participants scored the maximum points possible on the follow-up 
evaluation, which corresponded, to their respective posttest. With the small number of 
returned follow-up evaluations, no statistical tests were used to evaluate this data. Thus, it 
is not known if the second and third objectives were met. 
The fourth area of data evaluation was the use of the website (http://wvcamrsa.com). 
Both Google Analytics and Weebly Statistics were used to monitor use of the site. As of 
October 2, 2012, the total number of unique hits on the website was 565. During the 
investigation period, the mean number of unique hits on the website per day was eight. 
The home page received the most amount of hits followed by the antibiogram, CDC 
guidelines, I&D video, and the patient education resource. Direct hits on the website 
accounted for 94% of all the hits on the website. The most common referring search 
engine was Google accounting for 4% of the hits on the website, and the remaining 2% 
was made up from several other search engines. Thus, the fourth objective was met.  
The findings from this project demonstrated statistical significance. Practitioners 
did not demonstrate sufficient knowledge of CDC treatment guidelines, regional 
antibiograms, I&D technique, or patient educational materials before the multifocal 
training. This project supported the research finding that practitioners are confronted by 
several barriers in treating patients with SSTIs in the era of CA-MRSA, but when 
provided with tools to address these barriers are ready to treat CA-MRSA SSTIs 
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according to evidence-based guidelines. The number of hits on the website supported use 
of such a tool for future projects. The data from this project support the implementation 
of this project on a statewide level.   
Discussion 
 This research project provided several compelling findings. These findings were 
both general and specific in nature. The findings could be used to guide future research 
projects and more specifically assist practitioners in treatment of CA-MRSA SSTIs. 
Concerning the multifocal trainings, the investigator had concern about the 
reception and acceptance of a project by other disciplines. The investigator had hesitation 
that other practitioners with different hierarchical positions in the medical system would 
not be open or would be suspect of a project conducted by a nurse practitioner. The 
findings from this project did not support this concern. Practitioners, across the hierarchy, 
were open, appreciative, and receptive of this project. At no time in any of the six 
locations were the investigators’ concerns realized. It must be noted that community 
healthcare leaders/supporters, Janet Crigler and Beth Rosenberger, undoubtedly provided 
both access and perceived value to the project. Overall, this project supported the role of 
nurse practitioners as both initiators and promoters of evidenced-based care.   
Another interesting finding from the project was the questions most commonly 
missed on the pretest and posttest. The two most commonly missed questions on the 
pretest were “When treating a SSTI, you would provide empiric coverage for CA-MRSA 
if you know the prevalence in Marion County is greater than” and “In your experience 
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what is current prevalence of CA-MRSA in Marion County.” These two questions were 
answered incorrectly by 13 of the 22 participants on the pretest.  The incorrect responses 
signaled lack of knowledge of regional antibiograms and CA-MRSA prevalence within 
the community. The questions “When you are considering a diagnosis of an 
uncomplicated versus complicated SSTI, which one of the following criteria is least 
important” and “When you consider the susceptibility data for Marion County, which of 
the following would be the best choice for outpatient treatment of a complicated SSTI” 
were incorrectly answered by 10 of the 22 participants. These questions signaled lack of 
knowledge of treatment guidelines. The most commonly missed posttest question was 
“When you are considering a diagnosis of an uncomplicated versus complicated SSTI, 
which one of the following criteria is least important?” of which five participants had the 
incorrect response. The data supported that the multifocal training was successful in 
increasing practitioner knowledge in these critical areas.  
Another interesting assessment was the lack of time practitioners have to 
participate in activities such as the one that was presented in this project. When 
scheduling the trainings, it was evident that practitioners were bombarded from many 
different directions with each direction/person vying for the practitioner’s limited time 
and attention. It was noted that the key to successfully scheduling the meetings was the 
nurse or administrative assistant who often had significant input and control of the 
practitioner’s schedule. This assessment of lack of time may have also contributed to the 
relatively low number of completed follow-up evaluations. Six evaluations were 
received, but only two were completed entirely. Practitioners might have not considered 
!!
!
!
!
'+!
the follow -up evaluation a wise investment of their limited time or only chose to fill out 
the sections they deemed important. Overall, the benefit of this project was that it was 
relatively short in nature and provided practitioners with a resource website that could be 
used at a later time.  
Project Outcomes 
 The project’s outcomes supported future activities and trainings in the area of CA-
MRSA SSTIs on a local and state level.  Outcomes supported the idea that practitioners 
are interested in projects that not only provide knowledge, but address barriers that 
prevent or could prevent practitioners from implementing guidelines.  Technological 
advances, such as websites, are valuable tools for practitioners to put knowledge into 
practice. Lastly, the findings from this project support the need for this project to expand 
statewide so that all practitioners in WV can have access to guidelines, regional 
antibiograms, I&D technique, and patient educational materials when they are treating 
CA-MRSA SSTIs.  
Intervening Factors 
 Although attempts were made to decrease confounders in this project, there were 
several that were identified. The first factor that may have contributed to the results of the 
project was the lower than anticipated number of participants. The investigator’s goal 
was to train 50 practitioners during the project.  The project was conducted during the 
summer months. The investigator hypothesizes that the number of participants was lower 
than expected, because this is a common time for vacations and planned time off. For 
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future projects that desire higher participation, it would be of importance to choose a time 
of year that is not as common for vacations and time off.  
The second factor that may have contributed to the results was the practitioners’ 
past exposure to information on CA-MRSA SSTIs. The results from the pretest supported 
that practitioners had not been successful in retaining past knowledge on CA-MRSA 
SSTIs. The three-month follow-up evaluation was of importance to assess whether 
practitioners maintained knowledge and implemented that knowledge following the 
multifocal training. The low number of completed returned follow-up evaluations 
prevented statistical evaluation. All six participants who returned their follow-up 
evaluation reported use of the website resource and implementation of evidence-based 
practice in the treatment of CA-MRSA SSTIs.  
The last factor that may have affected results of this project was that the main 
resource for the project was computer/internet based. When asked about copies of the 
guidelines, antibiogram, patient education tools, and I&D video, the investigator did not 
give practitioners samples, but referred them to the website for downloading and printing 
of the resources. This methodology served two purposes for the project in that it limited 
the cost of printed materials and encouraged the participants to visit the website. Based 
on the number of hits on the website during the project, the site was readily used. 
However, practitioners who were neither comfortable nor interested in using this type of 
technology could have been limited in their use of the resource tool and may have 
benefited from handouts. This was an identified barrier that could have affected the 
results. 
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Theoretical Framework 
Everett Rogers’s theory of Diffusion of Innovations was used to guide this 
project. Rogers developed the theory of Diffusion of Innovations to explain and describe 
change. The theory’s five stages that occur in the adoption of an innovation were used to 
frame the steps to be taken to implement change in the treatment of CA-MRSA SSTIs. 
This theory and the framework it provided were a perfect fit for this project. The theory 
provided framework, but was not rigid. Practitioners were moved from lack of 
knowledge, to knowledge, and then to implementation in the treatment of CA-MRSA 
SSTIs. An important factor in promoting change for this project and moving practitioners 
from to knowledge to implementation was the availability of the website tool. 
Practitioners reported that in the past they had knowledge of the guidelines, but failed to 
implement them because of lack of tools to address the barriers. Practitioners reported 
that the website provided them with the necessary resources to overcome barriers that 
would have otherwise prevented the move to implementation. For future projects 
promoting change, researchers should identify common barriers and then provide a user-
friendly website resource.   
Implications 
Further Practice Implications 
Findings of the systematic review that was conducted for this project, highlighted 
issues that health care providers should consider with respect to their own practice. 
Consistency in identification, classification and treatment of pediatric CA-MRSA SSTIs 
!!
!
!
!
($!
is essential. In practices with multiple partners, a standardized classification and 
treatment plan is recommended. Practitioners should agree on the SSTIs classification 
that warrants use of antibiotics, to enable continuity of care and allow for follow up data 
on efficacy to be collected. When I&D is provided as treatment, consistency in 
performance across clinicians is also important. Duration of follow up for pediatric 
patients treated for CA-MRSA SSTIs needs to be adequate to assess for both short- and 
long-term resolution of infection. And, finally, education to equip families for prevention 
and early recognition is a key element in the comprehensive management of CA-MRSA 
SSTIs 
This project was the first of its kind in Marion County, WV and proved to have 
statistically significant results. This project was supported by the previously mentioned 
systematic review. It was in congruence with FGH’s mission of “making a difference in 
people’s lives.” Practitioners were moved from knowledge to implementation of 
evidence-based guidelines when treating CA-MRSA SSTIs. In the planning stages for the 
project, dialogue was initiated with the WVDHHR. During this dialogue with 
WVDHHR, it was suggested that this project be “piloted” in one county.  If statistically 
significant results were achieved in one county, it would then be considered for statewide 
adoption. The statistically significant results of this project will be sent to WVDHHR for 
consideration for statewide adoption and at minimum linking the website for this project 
to the WVDDHR website as a resource for practitioners across WV. 
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Implications for DNP Practice 
 CA-MRSA SSTIs are proving to be prominent in the community, contagious, 
difficult to treat and eradicate, and at times, lethal. Dermatology specialists including 
medical doctors, APNs, and nurses are actively engaged in the battle to treat the current 
infections without creating further bacterial resistance. Zaccagnini and White (2011) 
differentiated medicine from nursing, when they wrote that medicine focuses on the 
diagnosis and treatment of disease, but nursing focuses on the human response to illness 
and its treatment. Parse (1992) also contributed when she explained, “nursing science has 
a unique body of knowledge that contains theories and evidence intuited, observed, and 
tested by nurses involved in the process of human health.” Therefore, the advance 
practice nurse (APN) can address CA-MRSA’s treatment and prevention from a caring 
perspective that utilizes unique nursing skills, theories, and body of knowledge in an 
evidenced-based manner.!!
With the understanding of the value of the APN practicing at its highest level 
within the healthcare system, The American College of Nursing (2006) published The 
Essentials of Doctoral Education for Advanced Nursing Practice. This document serves 
as a guide for developing Doctor’s of Nursing Practice (DNP) programs so that the DNP 
trained APN will embody the highest level of leadership and expertise in specific areas of 
clinical practice.  This document also helped differentiate between the PhD and the DNP. 
The PhD in nursing was seen as developing new knowledge and the DNP as using 
knowledge that already exists and putting it into practice.  As the nursing profession 
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continues to grow in its development and use of theory in education, practice, and 
research, both the PhD and DNP will prove invaluable. 
This capstone project demonstrated several characteristics outlined in the 
American College of Nursing’s (2006) The Essentials of Doctoral Education for 
Advanced Nursing Practice that demonstrate the role of the DNP.  The first characteristic 
that was demonstrated was the use of scientific underpinnings for practice. This project 
was based on systematic review CA-MRSA SSTIs that searched the literature for the 
highest level of evidence available. The results of this systematic review provided the 
basis and support from the literature. This project also used a theory from the social 
sciences as its framework. By doing so, it demonstrated the integration of knowledge 
from nursing with other disciplines to further demonstrate nursing practice on its highest 
level.  
The second DNP characteristic that was demonstrated was ability to provide 
organizational and systems leadership for quality improvement. The investigator realized 
that for this project to have long-term impact and to bring about real practice change, that 
it must be integrated or coordinated with existing agencies or health providers. This 
project involved consulting and working with the WVDHHR, FGH, and several practices 
within Marion County. The investigator analyzed the systems that were in place and the 
services that were being provided. Through this analysis, the investigator realized that 
many of the components for providing evidence-based care in the treatment of CA-
MRSA SSTIs existed, but were not cohesive. The investigator also identified that 
providing a resource to practitioners would also decrease healthcare cost and unnecessary 
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side effects from unwarranted antibiotic use. This project provided cohesion by bringing 
the necessary components and resources together and presented it to practitioners so that 
they could provide high quality cost effective care to their patients.   
The third characteristic that was demonstrated during this project that reflected an 
APN with DNP training was the use of technology and informational systems to improve 
patient care. In the nursing profession, technology has been resisted at times because of 
concerns about how it would affect the quintessence of nursing, patient care. However, 
the DNP nurse is able to leverage technology to provide more efficient and quality care, 
rather than diminish or detract from it. For this project, a website was developed as a 
learning and resource tool for practitioners. The investigator had no experience in website 
development, but was convinced it was paramount to the project’s success. With input 
from professionals with website development skills and insight from experts in 
healthcare, a quality website was developed without expending large amount of 
resources. The website provided practitioners with the ability to access the resource from 
any location where they had internet connection. This technology reduced the cost of 
printing and distributing handouts, but also provided the resource in a user-friendly 
cohesive manner.  
Implications for Future Research 
This capstone project supported that practitioners can be moved through the 
change process if common barriers that would prevent implementation are addressed. 
Practitioners must not only be equipped with knowledge, but the tools and resources to 
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address barriers. There were several areas that were identified that warrant more research 
concerning the treatment of CA-MRSA SSTIs.  
The systematic review identified important areas that need further research. 
Future research should focus on RCTs, specifically in the pediatric population, include a 
standardized, reliable, method for identification of CA-MRSA, and provide clear and 
explicit definitions of uncomplicated versus complicated SSTIs. Consideration of how 
short and long-term resolution and treatment failure should be defined and measured, is 
important to support confidence in treatment effect. In the area of resolution of infection, 
future studies could also focus on the both the short and long-term benefits of using 
antibiotics with the sentinel SSTI. If I&D is adequate to treat the initial SSTI and provide 
short-term resolution, but subsequent lesions occur days and months after, then it may be 
necessary to consider long-term resolution and possibly antibiotic use when initially 
treating the sentinel lesion. Each of these topics is paramount to provide better care for 
patients and to provide a more specific standard of treatment.  
Another area that was warrants further research is the whether information 
technology is acceptable for practitioners across the generational and professional 
spectrum. Studies could focus on whether or not there is generational differences in 
adoption of technology and if so what actions could be taken to reduce stress in the 
adoption process. Research could also focus on evaluating if specific disciplines are more 
apt to use information technology and how the DNP compares to other professions.  
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This research project did not identify that other disciplines were resistant to an 
APN introducing change, but this area also warrants further exploration and research. 
Studies could focus on whether or not change is more readily accepted if the change is 
introduced inter or intra professionally. Researchers could also focus on whether or not 
practitioners are willing to move through the change process if a doctoral trained 
practitioner versus non-doctoral trained practitioner presents the innovation. Each of 
these proposed areas concerning the change process could identify areas that would 
decrease the frustration sometimes felt by the change agent and the participants.  
Implications for Education 
 The concept of evidence-based practice has been met with mixed responses in the 
practitioner community.!At times, nursing has resisted evidence-based practice as 
something that medicine has developed and is not applicable to the art of nursing. 
Individuals in the medical community have also resisted evidence-based practice as 
something that turns medicine into a “cookie cutter” methodology.  Therefore, educating 
practitioners on evidence-based guidelines can be difficult due to these barriers and 
resistance to change. During the systematic review, the researcher identified two very 
important strategies that could assist when educating practitioners. If these strategies are 
adopted, it is possible that education can more rapidly move from knowledge to 
implementation.  
The first strategy was that including practitioners in discussions concerning 
guidelines was more effective than just providing guidelines for changing practitioner 
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practice.  Coles (2002) also supported this by contributing that professional judgement is 
often gained through interaction and conversations with respected colleagues, rather than 
didactic sessions. Practitioners have traditionally functioned under cognitive dissonace, 
being rewarded for what they know, but not being rewarded for asking questions and 
seeking out answers. This system does not allow for the interaction and conversations 
that this project has identified as beneficial. During the education of practitioners, it 
would be beneficial to introduce a more balanced approach and one that relies less on 
cognitive dissonance and more on interaction and inquiry.  
The second strategy for educating practitioners in evidence-based practice is 
equipping them with resources to address common barriers.  Although this appears 
simplistic, it is an area that can be neglected. During this project, the investigator 
ascertained that practitioners had heard of the guidelines that were available for treatment 
of CA-MRSA SSTIs, but resisted change because they were not provided with resources 
to address the barriers. If practitioners are to adopt evidence-based practice, the training 
must move beyond information only, but must include educating practitioners on 
available resources.  
Summary 
Despite current recommendations for incision and drainage (I&D) to be the 
primary treatment for uncomplicated CA-MRSA SSTIs (Gorwitz, 2008; Liu et al., 2011), 
substantial practice variation in use of I&D and antibiotic prescription persist (Baumann, 
2011; Hersh et al., 2009). Increasing consistency and use of evidence-based care is 
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important to both prevent inadequate treatment and improve patient outcomes. 
Appropriate antibiotic prescribing practices are particularly important to help reduce the 
spread of antibiotic resistance (Gorwitz, 2008). Evidence-based practice can potentially 
both improve patient outcomes and reduce the risk of adverse outcomes.  
The purpose of this project was to train practitioners in Marion County, WV on 
the CDC guidelines for treatment of CA-MRSA SSTIs and to provide resources to 
address some of the most common barriers that inhibit practitioners from using the 
guidelines.  Research supports the use of these guidelines and has also supported that 
there are common barriers to not using the guidelines.  Evidence-based treatment of 
SSTIs is imperative to decreasing the rapidity of antibiotic resistance and practicing 
antibiotic stewardship.  
The findings from this project demonstrated statistical significance. Practitioners 
do not have sufficient knowledge of CDC treatment guidelines, regional antibiograms, 
I&D technique, or patient educational materials. This project supported the research 
finding that practitioners are confronted with several barriers in treating patients with 
SSTIs in the era of CA-MRSA. When provided with tools to address these barriers they 
are ready to treat CA-MRSA SSTIs according to evidence-based guidelines. The number 
of hits on the website supported use of information technology for future projects. The 
findings from this project support the implementation on a statewide level.   
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Attainment of Leadership Goals 
 Conducting a research project as part of my DNP educational experience has 
provided enrichment to my leadership skills. The first step of searching the literature and 
formulating a systematic review gave me the confidence and skill to examine existing 
research and synthesize it for use in clinical practice.  Applying the research to my 
clinical practice has allowed me to become an expert on the subject in Marion County 
with other practitioners consulting with me for direction on clinical treatment to improve 
their patients’ outcomes.  
During the development and implementation of this project, I had the privilege of 
working with leaders at FGH and other independent clinics. The insight gained from 
these leaders provided confidence during the project implementation. I deduced that 
leaders must have great leaders around them to be successful. I trust that as I become a 
leader in nursing, I will be able to mentor others as I have been mentored.  
After completion of this capstone project, WVDHHR will be contacted for the 
purpose of working with them to launch the project statewide. The results of the 
systematic review have already been published, but opportunities will also be sought to 
publish the results of the entire project. The goal of publishing and sharing the results 
would be to encourage others to engage in evidence- based practice and to develop 
projects that would build off of this one.  
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Appendix A - Capstone Budget          
Estimated Cost Actual 
Webpage development 
 Weebly       $39.95  $39.95 
 Development Hours  (10hrs X 30.00)            $300.00      0.00  
Educational Teachings 
 Lunches/Dinners 
A. Fairmont Clinic         0.00                 0.00  
B. Manchin Clinic     $50.00                           75.00 
C. Whitehall Clinic     $50.00     25.00 
D. Marion County Medical        0.00       0.00 
            Gas        $20.00     25.00 
Nursing CEUs/ CMEs                    0.00 
Cards-Follow-up/Thank you     $50.00   $50.00 
Labor (5 hours X 30.00)                         $150.00                       $150.00 
 
Evaluations 
 Paper         $6.00                  0.00 
 Photo Copies          0.00                             0.00 
 Survey Monkey         0.00                             0.00 
 
Total                 $665                             $314
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Appendix B- CA-MRSA Website for Marion County, WV .//01223#45678593::;<=94>6!
CA-MRSA Skin and Soft Tissue Infections Marion County, WV 2012 
 
 
 Home 
 CDC Guidelines 
 Antibiogram 
 Incision and Drainage 
 Patient Education Tool 
 Patient Education Tool 
 Sources 
 
 
Evidenced Based Treatment Treatment of pediatric patients with community-acquired 
methicillin resistant staphylococcus aureus (CA-MRSA) skin and soft tissue infections 
(STTI) is a major  
Figure 2  p.2 
challenge and concern in the global healthcare community. These infections are rapidly 
becoming more prevalent and prevention of further antibiotic resistance is of paramount 
importance. Primary health care providers need to know the most effective method of 
treatment and control of CA-MRSA SSTIs in the pediatric population to achieve 
resolution of infection, prevent adverse health outcomes, and limit spread of the 
infection.  
Appendix- MRSA: What you should know 
 
! !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!)%!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
!
!
)%!
Appendix C- Patient/Family Education Tool Michigan Department of Health 
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Appendix D- Options for empiric outpatient treatment when MRSA is a consideration   
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Appendix E- Antibiogram  Fairmont General Hospital 2011 
   Staph Aureus 
Trimeth/Sulfa  100% 
Tetracycline  98% 
Rifampin  100% 
Cefazolin  43% 
Clindamycin  61% 
Vancomycin  100% 
Oxacillin  43% 
Linezolid  100% 
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Appendix F. Outline of educational session for practitioners  
A. Introduction 
1. Purpose of session 
2. Background and significance of CA-MRSA SSTIs 
3. Statement of the Problem: The prevalence of pediatric community- 
acquired methicillin-resistant staphylococcus aureus (CA-MRSA) skin and      
soft tissue infections (SSTIs) have been well documented, yet evidence 
supporting treatment standards for short-and long-term resolution is 
equivocal. Treatment changes are paramount in the fight against CA-
MRSA and practitioners must follow the clinical practice guidelines and 
begin to utilize incision and drainage (I&D) more frequently and 
antibiotics less frequently. 
4. Literature review and synthesis 
5. Project 
a. Guiding theory 
b. Population 
c. Objectives 
d. Committee 
e. Timeline  
f. Evaluation 
B. PICO statement- What is the effect of a pilot program that educates  practitioners       
with treatment guidelines, regional susceptibility data, and incision and drainage 
(I&D) technique versus common treatment practices to increase practitioner’s 
knowledge and utilization of evidence based guidelines in the treatment of 
pediatric CA-MRSA SSTI over a three-month period? 
C. CDC guidelines for treatment of CA-MRSA SSTIs 
a. Brief overview of guidelines  
b. Common barriers to use of guidelines 
D. Antibiogram for Marion County 
a. Brief epidemiology 
b. Review of antibiogram and prescribing 
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E. Incision and Drainage 
a. Technique 
b. Barriers to use 
F. Patient Education Tool 
a. Michigan Antibiotic Resistance Reduction 
b. Use of tool 
G. Website 
H. Interaction and Questions 
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Appendix G- Pretest/Posttest 
For the current project, the purpose of this test is to ascertain practice patterns of 
practitioners when treating for CA-MRSA skin and soft tissue infections (SSTIs) in 
Marion County, WV.!
1.  In what age group do most CA-MRSA skin and soft tissue infections (SSTIs) 
occur? 
 a. 1 month-19 years 
 b. 20-30 years 
 c. 40-60 years 
 d. 70- 90 years 
2. When treating a SSTI, you would provide empiric coverage for CA-MRSA if you 
know the prevalence in Marion County is greater than? 
 a. 5-10% 
 b. 10-15% 
 c. 15-20% 
 d. > 20% 
3.In your experience what is current prevalence of CA-MRSA in Marion County? 
 a. 20-30% 
 b. 31-40% 
 c. 41-50% 
 d. 51-60% 
5. While awaiting culture results, which antibiotic is an appropriate choice for an 
otherwise healthy 18- year old male Marion County resident with a 6cm single 
lesion abscess on his buttocks 
      a. Rocephin  
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 b. Doxycycline  
 c. Keflex  
 d. Augmentin  
6. Which of the following complies with established treatment guidelines to treat 
uncomplicated CA-MRSA SSTIs? 
 a. I&D plus doxycycline 
 b. I&D alone 
 c. Bactrim without I&D 
 d. I&D plus vancomycin 
7. When you are considering a diagnosis of an uncomplicated versus complicated 
SSTI, which one of the following criteria  is least important? 
 a. age of patient 
 b. location of infection 
 c.  occupation of patient 
 d. co- morbid conditions 
8.  When you consider the susceptibility data for Marion County, which of the 
following would be the best choice for outpatient treatment of a complicated 
SSTI?  
 a. Keflex 
 b. Bactrim 
 c. Clindamycin 
 d. Minocycline 
11.  After performing I&D, what antibiotic may protect against subsequent infections 
for the outpatient?  
 A. Doxycycline 
 B. Bactrim 
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 C. Vancomycin 
 D. Ceftriaxone 
13. Is I&D part of your treatment regimen for those who present with a CA-MRSA 
skin and soft tissue infection? (Y/N) 
14. If you answered “No” to question 13, which of the following acts as a barrier for 
you from performing I&D? Circle all that apply 
 A. Do not perform I&D frequently enough to feel comfortable with it. 
 B. Lack supplies for performing I&D 
 C. Do not have time to perform I&D 
 D. Prefer for prescribe antibiotics rather than perform I&D  
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Appendix H- Three month follow-up evaluation 
For the current project, the purpose of this test is to ascertain practice patterns for the 
treatment of  CA-MRSA skin and soft tissue infections (SSTIs) in Marion County, WV.!
1. In the last three months, have you treated a patient for a CA-MRSA SSTIs 
(Yes/No)? 
2. Did you use the website (http://wvcamrsa.weebly.com)? (yes/no) 
 
            IF YES: 
            Did it help to decrease some of the barriers…  (yes/no) 
Rate the helpfulness on a scale of 1 (not at all helpful) to 5 (very helpful) for each    
component: 
               
Guidelines   1 2 3 4 5 
            Susceptibility Data  1 2 3 4 5 
            I&D Video  1 2 3 4 5 
Patient Education Tool  1 2 3 4 5 
 
 
3. Are you currently following CDC guidelines? (yes/no/unsure 
      Did the educational session change your treatment regimen?  (yes/no) 
      If not, why? 
           A.   I was already treating in line with CDC guidelines. 
           B.   I am continuing to use a treatment regimen I prefer over the CDC       
     guidelines. 
     C.   I still have barriers that prevent me from implementing CDC guidelines 
4.   In what age group do most CA-MRSA skin and soft tissue infections (SSTIs) 
occur? 
 a. 1 month-19 years 
 b. 20-30 years 
 c. 40-60 years 
 d. 70- 90 years 
5. When treating a SSTI, you would provide empiric coverage for CA-MRSA if you 
know the prevalence in Marion County is greater than  
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 a. 5-10% 
 b. 10-15% 
 c. 15-20% 
 d. > 20% 
6.In your experience what is current prevalence of CA-MRSA in Marion County? 
 a. 20-30% 
 b. 31-40% 
 c. 41-50% 
 d. 51-60% 
7. While awaiting culture results, which antibiotic is an appropriate choice for an 
otherwise healthy 18- year old male Marion County resident with a 6cm single 
lesion abscess on his buttocks 
      a. Rocephin  
 b. Doxycycline  
 c. Keflex  
 d. Augmentin  
8. Which of the following complies with established treatment guidelines to treat 
uncomplicated CA-MRSA SSTIs? 
 a. I&D plus doxycycline 
 b. I&D alone 
 c. Bactrim without I&D 
 d. I&D plus vancomycin 
9. When you are considering a diagnosis of an uncomplicated and/or complicated 
SSTIs, which one of the following criteria is least important? 
 a. age of patient 
 b. location of infection 
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 c.  occupation of patient 
 d. co- morbid conditions 
10.  When you consider the susceptibility data for Marion County, which of the 
following would be the best choice for outpatient treatment of a complicated 
SSTI?  
 a. Keflex 
 b. Bactrim 
 c. Clindamycin 
 d. Minocycline 
11.  After performing I&D, what antibiotic may protect against subsequent infections 
for the outpatient?  
 A. Doxycycline 
 B. Bactrim 
 C. Vancomycin 
 D. Ceftriaxone 
12. Is I&D part of your treatment regimen for those who present with a CA-MRSA 
skin and soft tissue infections? (Yes/No) 
13. If you answered “No” to question 13, which of the following prevent you from 
performing I&D? Circle all that apply 
 A. Do not perform I&D enough to feel comfortable with it. 
 B. Lack supplies for performing I&D 
 C. Do not have time to perform I&D 
 D. Prefer for prescribe antibiotics rather than perform I&D.  
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